My Gene Counsel's confirmatory testing program is the latest example of how the healthcare system is adapting to consumers' growing appetite for genetic testing.
23andMe is now offering a type 2 diabetes risk test, according to MIT's Technology Review.
Healthcare providers continue to worry about the impact of 23andMe's health risk reports but there is also growing acceptance of the DTC testing model.
At-home genetic tests can uncover family secrets and lead those who uncover them to seek out support groups, the Boston Globe reports.
The revelation that Family Tree DNA has been working with law enforcement has some worried about a negative impact on the industry.
The New York Times warns in an editorial that 23andMe health risk tests may not provide useful information.
Using UK Biobank and 23andMe data, researchers found 352 loci influencing sleep time preferences, including sites near brain- and retina-expressed genes.
Direct-to-consumer genetic testing firm 23andMe has a newly cleared colorectal cancer risk test.
The clearance enables 23andMe to report on the two most common variations in the MUTYH gene influencing MAP, which increases risk of CRC development.
Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.
Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.
Wired reports that researchers have shown they could reprogram a DNA-based computer.
Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.
In Science this week: whole-genome sequencing of single sperm cells, and more.